LOGIN
Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis
January 2022
Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial.
Adv Orthop. 2021 Nov 20;2021: 2146722.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixty patients aged 45-70 years old with knee osteoarthritis were randomized to receive a single intra-articular injection of autologous bone marrow-derived chondrocytes (n=30) or physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs). Outcomes of interest included pain on a Visual Analog Scale (VAS) with and without movement, the Modified Knee Society Score-Short Form (KSSSF), Activit...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.